Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad 382213, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 60219-1502-01
Published February 14, 2024 · Recall initiated: January 15, 2024
Summary
FDA records drug Class II recall D-0319-2024, published February 14, 2024 and initiated January 15, 2024. Recalling firm: Amneal Pharmaceuticals of New York, LLC; Status: Terminated; Reported quantity: 858 bottles; Lot: Lot # AM221153, Exp. date 06/30/2024; AM230497, Exp. date 02/29/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Amneal Pharmaceuticals of New York, LLC
- Distributor
- USA nationwide.
- Lot
- Lot # AM221153, Exp. date 06/30/2024; AM230497, Exp. date 02/29/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAExenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For SingleSeptember 30, 2026
- FDAMethylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only, Distributed by: AmnealMay 8, 2024
- FDAVancomycin Hydrochloride for Oral Solution, USP, 250 mg per 5 mL, packaged as (a) 80 mL bottle, NDCApril 24, 2024
- FDADivalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: AmnealApril 3, 2024
- FDALansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma LimitedFebruary 14, 2024
- FDAHydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100-count (10 x 10) per unit dose carton, Rx Only, DistributedFebruary 14, 2024
Questions about this recall
Was Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad 382213, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 60219-1502-01 recalled?
Yes. FDA published recall D-0319-2024 on February 14, 2024. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
What should I do if I have this product?
Voluntary: Firm initiated · Letter